Lung-gut cross-talk: Evidence, mechanisms and implications for the mucosal inflammatory diseases

Clinical and Experimental Allergy

Volumn 46, Issue 4, 2016, Pages 519-528

  Tulic, M K ^a,b   Piche, T ^a,c   Verhasselt, V ^a,b  

^a UNIVERSITÉ CÔTE D'AZUR   (France)

^b International Inflammation Network (in FLAME) of the World Universities Network   (Australia)

^c CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGIC DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; HUMAN; INFLAMMATORY BOWEL DISEASE; INFLAMMATORY DISEASE; INTESTINE; LUNG; MICROFLORA; MUCOSAL IMMUNITY; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; HYPERSENSITIVITY; IMMUNOLOGY; INFLAMMATION; INFLAMMATORY BOWEL DISEASES; METABOLISM; MUCOSA; PATHOLOGY; PHYSIOLOGICAL FEEDBACK; PHYSIOLOGY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

ANIMALS; FEEDBACK, PHYSIOLOGICAL; HUMANS; HYPERSENSITIVITY; IMMUNITY, MUCOSAL; INFLAMMATION; INFLAMMATORY BOWEL DISEASES; INTESTINES; LUNG; MUCOUS MEMBRANE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 84961635283     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/cea.12723     Document Type: Review

References (106)

1. Bienenstock J, McDermott M, Befus D, O'Neill M. A common mucosal immunologic system involving the bronchus, breast and bowel. Adv Exp Med Biol 1978; 107:53-9.
2. Gallichan WS, Woolstencroft RN, Guarasci T, McCluskie MJ, Davis HL, Rosenthal KL. Intranasal immunization with CpG oligodeoxynucleotides as an adjuvant dramatically increases IgA and protection against herpes simplex virus-2 in the genital tract. J Immunol 2001; 166:3451-7.
3. Artenstein AW, VanCott TC, Sitz KV et al. Mucosal immune responses in four distinct compartments of women infected with human immunodeficiency virus type 1: a comparison by site and correlation with clinical information. J Infect Dis 1997; 175:265-71.
4. Sobko T, Schiott J, Ehlin A, Lundberg J, Montgomery S, Norman M. Neonatal sepsis, antibiotic therapy and later risk of asthma and allergy. Paed Perinatal Epidemiol 2010; 24:88-92.
5. Trompette A, Gollwitzer ES, Yadava K et al. Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis. Nature Med 2014; 20:159-66.
6. Wang H, Liu JS, Peng SH et al. Gut-lung crosstalk in pulmonary involvement with inflammatory bowel diseases. World J Gastroenterol 2013; 19:6794-804.
7. Southam DS, Dolovich M, O'Byrne PM, Inman MD. Distribution of intranasal instillations in mice: effects of volume, time, body position, and anesthesia. Am J Physiol 2002; 282:L833-9.
8. Turner-Warwick M. Fibrosing alveolitis and chronic liver disease. Quarterly J Med 1968; 37:133-49.
9. Kraft SC, Earle RH, Roesler M, Esterly JR. Unexplained bronchopulmonary disease with inflammatory bowel disease. Arch Internal Med 1976; 136:454-9.
10. Rogers BH, Clark LM, Kirsner JB. The epidemiologic and demographic characteristics of inflammatory bowel disease: an analysis of a computerized file of 1400 patients. J Chronic Dis 1971; 24:743-73.
11. Edwards FC, Truelove SC. The course and prognosis of ulcerative colitis. III. Complications. Gut 1964; 5:1-22.
12. Bernstein CN, Blanchard JF, Rawsthorne P, Yu N. The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study. Am J Gastroenterol 2001; 96:1116-22.
13. Rothfuss KS, Stange EF, Herrlinger KR. Extraintestinal manifestations and complications in inflammatory bowel diseases. World J Gastroenterol 2006; 12:4819-31.
14. Powell N, Walker MM, Talley NJ. Gastrointestinal eosinophils in health, disease and functional disorders. Nat Rev 2010; 7:146-56.
15. Kuzela L, Vavrecka A, Prikazska M et al. Pulmonary complications in patients with inflammatory bowel disease. Hepato-Gastroenterol 1999; 46:1714-9.
16. Mohamed-Hussein AA, Mohamed NA, Ibrahim ME. Changes in pulmonary function in patients with ulcerative colitis. Respir Med 2007; 101:977-82.
17. Duricova D, Pedersen N, Elkjaer M, Gamborg M, Munkholm P, Jess T. Overall and cause-specific mortality in Crohn's disease: a meta-analysis of population-based studies. Inflamm Bowel Dis 2010; 16:347-53.
18. Keely S, Talley NJ, Hansbro PM. Pulmonary-intestinal cross-talk in mucosal inflammatory disease. Mucosal Immunol 2012; 5:7-18.
19. Black H, Mendoza M, Murin S. Thoracic manifestations of inflammatory bowel disease. Chest 2007; 131:524-32.
20. Peng YH, Liao WC, Su CH et al. Association of inflammatory bowel disease with asthma risk: a nationwide cohort study. Allergy Asthma Proc 2015; 36:92-8.
21. Munck A, Murciano D, Pariente R, Cezard JP, Navarro J. Latent pulmonary function abnormalities in children with Crohn's disease. Eur Respir J 1995; 8:377-80.
22. Sampson HA. Update on food allergy. J Allergy Clin Immunol 2004; 113:805-19; quiz 820.
23. Brandt EB, Scribner TA, Akei HS, Rothenberg ME. Experimental gastrointestinal allergy enhances pulmonary responses to specific and unrelated allergens. J Allergy Clin Immunol 2006; 118:420-7.
24. Williams AE, Edwards L, Hussell T. Colonic bacterial infection abrogates eosinophilic pulmonary disease. J Infect Diseases 2006; 193:223-30.
25. Verhasselt V, Milcent V, Cazareth J et al. Breast milk-mediated transfer of an antigen induces tolerance and protection from allergic asthma. Nature Med 2008; 14:170-5.
26. Zuercher AW, Jiang HQ, Thurnheer MC, Cuff CF, Cebra JJ. Distinct mechanisms for cross-protection of the upper versus lower respiratory tract through intestinal priming. J Immunol 2002; 169:3920-5.
27. Ruane D, Brane L, Reis BS et al. Lung dendritic cells induce migration of protective T cells to the gastrointestinal tract. J Exp Med 2013; 210:1871-88.
28. Akdis CA, Akdis M. Mechanisms of allergen-specific immunotherapy. J Allergy Clin Immunol 2011; 127:18-27; quiz 28-19.
29. Burks AW, Wood RA, Jones SM et al. Sublingual immunotherapy for peanut allergy: long-term follow-up of a randomized multicenter trial. J Allergy Clin Immunol 2015; 135:1240-1248 e1241-1243.
30. Amar SM, Harbeck RJ, Sills M, Silveira LJ, O'Brien H, Nelson HS. Response to sublingual immunotherapy with grass pollen extract: monotherapy versus combination in a multiallergen extract. J Allergy Clin Immunol 2009; 124:150-156 e151-155.
31. Bufe A, Eberle P, Franke-Beckmann E et al. Safety and efficacy in children of an SQ-standardized grass allergen tablet for sublingual immunotherapy. J Allergy Clin Immunol 2009; 123:167-73e167.
32. Durham SR, Emminger W, Kapp A et al. Long-term clinical efficacy in grass pollen-induced rhinoconjunctivitis after treatment with SQ-standardized grass allergy immunotherapy tablet. J Allergy Clin Immunol 2010; 125:131-138.
33. Yang IV, Schwartz DA. Epigenetic control of gene expression in the lung. Am J Respir Crit Care Med 2011; 183:1295-301.
34. Lundback B, Lindberg A, Lindstrom M et al. Not 15 but 50% of smokers develop COPD?-Report from the Obstructive Lung Disease in Northern Sweden Studies. Respir Med 2003; 97:115-22.
35. Ekbom A, Brandt L, Granath F, Lofdahl CG, Egesten A. Increased risk of both ulcerative colitis and Crohn's disease in a population suffering from COPD. Lung 2008; 186:167-72.
36. Jess T, Loftus EV Jr, Harmsen WS et al. Survival and cause specific mortality in patients with inflammatory bowel disease: a long term outcome study in Olmsted County, Minnesota, 1940-2004. Gut 2006; 55:1248-54.
37. Beloborodova EI, Akimova LA, Burkovskaia BA, Asanova AV, Semenenko EV. Activity of systemic inflammatory reaction in patients with chronic obstructive pulmonary disease in regard to small intestinal absorption function. Ter Arkh 2009; 81:19-23.
38. Fedorova TA, Spirina L, Chernekhovskaia NE et al. The stomach and duodenum condition in patients with chronic obstructive lung diseases. Klin Med 2003; 81:31-3.
39. Heijink IH, Brandenburg SM, Postma DS, van Oosterhout AJ. Cigarette smoke impairs airway epithelial barrier function and cell-cell contact recovery. Eur Respir J 2012; 39:419-28.
40. Thomas GA, Rhodes J, Green JT, Richardson C. Role of smoking in inflammatory bowel disease: implications for therapy. Postgrad Med J 2000; 76:273-9.
41. Rutten EP, Lenaerts K, Buurman WA, Wouters EF. Disturbed intestinal integrity in patients with COPD: effects of activities of daily living. Chest 2014; 145:245-52.
42. Sommer F, Backhed F. The gut microbiota-masters of host development and physiology. Nature Rev 2013; 11:227-38.
43. Gollwitzer ES, Marsland BJ. Impact of early-life exposures on immune maturation and susceptibility to disease. Trends Immunol 2015; 36:684-96.
44. Xu Z, Knight R. Dietary effects on human gut microbiome diversity. Brit J Nutr 2015; 113(Suppl):S1-5.
45. Frank DN, St Amand AL, Feldman RA, Boedeker EC, Harpaz N, Pace NR Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. PNAS 2007; 104:13780-5.
46. Human Microbiome Project. C. A framework for human microbiome research. Nature 2012; 486:215-21.
47. Human Microbiome Project. C. Structure, function and diversity of the healthy human microbiome. Nature 2012; 486:207-14.
48. Hui AW, Lau HW, Chan TH, Tsui SK. The human microbiota: a new direction in the investigation of thoracic diseases. J Thoracic Dis 2013; 5(Suppl 2):S127-31.
49. Hviid A, Svanstrom H, Frisch M. Antibiotic use and inflammatory bowel diseases in childhood. Gut 2011; 60:49-54.
50. Grehan MJ, Borody TJ, Leis SM, Campbell J, Mitchell H, Wettstein A Durable alteration of the colonic microbiota by the administration of donor fecal flora. J Clin Gastroenterol 2010; 44:551-61.
51. West CE, Renz H, Jenmalm MC et al. The gut microbiota and inflammatory noncommunicable diseases: associations and potentials for gut microbiota therapies. J Allergy Clin Immunol 2015; 135:3-13; quiz 14.
52. Cooke KR, Hill GR, Gerbitz A et al. Hyporesponsiveness of donor cells to lipopolysaccharide stimulation reduces the severity of experimental idiopathic pneumonia syndrome: potential role for a gut-lung axis of inflammation. J Immunol 2000; 165:6612-9.
53. Noverr MC, Huffnagle GB. Does the microbiota regulate immune responses outside the gut? Trends Microbiol 2004; 12:562-8.
54. Noverr MC, Noggle RM, Toews GB, Huffnagle GB. Role of antibiotics and fungal microbiota in driving pulmonary allergic responses. Infect Immunity 2004; 72:4996-5003.
55. Gollwitzer ES, Saglani S, Trompette A et al. Lung microbiota promotes tolerance to allergens in neonates via PD-L1. Nature Med 2014; 20:642-7.
56. Thorburn AN, McKenzie CI, Shen S et al. Evidence that asthma is a developmental origin disease influenced by maternal diet and bacterial metabolites. Nature Comm 2015; 6:7320.
57. Thorburn AN, Macia L, Mackay CR. Diet, metabolites, and "western-lifestyle" inflammatory diseases. Immunity 2014; 40:833-42.
58. Herbst T, Sichelstiel A, Schar C et al. Dysregulation of allergic airway inflammation in the absence of microbial colonization. Am J Respir Crit Care Med 2011; 184:198-205.
59. Russell SL, Gold MJ, Hartmann M et al. Early life antibiotic-driven changes in microbiota enhance susceptibility to allergic asthma. EMBO 2012; 13:440-7.
60. Abrahamsson TR, Jakobsson HE, Andersson AF, Bjorksten B, Engstrand L, Jenmalm MC Low diversity of the gut microbiota in infants with atopic eczema. J Allergy Clin Immunol 2012; 129:434-40, 440 e431-432.
61. Abrahamsson TR, Jakobsson HE, Andersson AF, Bjorksten B, Engstrand L, Jenmalm MC Low gut microbiota diversity in early infancy precedes asthma at school age. Clin Exp Allergy 2014; 44:842-50.
62. Bisgaard H, Li N, Bonnelykke K et al. Reduced diversity of the intestinal microbiota during infancy is associated with increased risk of allergic disease at school age. J Allergy Clin Immunol 2011; 128:646-652 e641-645.
63. Tsay TB, Yang MC, Chen PH, Hsu CM, Chen LW. Gut flora enhance bacterial clearance in lung through toll-like receptors 4. J Biomed Sci 2011; 18:68.
64. Harris JK, De Groote MA, Sagel SD et al. Molecular identification of bacteria in bronchoalveolar lavage fluid from children with cystic fibrosis. PNAS 2007; 104:20529-33.
65. Huang YJ, Kim E, Cox MJ et al. A persistent and diverse airway microbiota present during chronic obstructive pulmonary disease exacerbations. OMICS 2010; 14:9-59.
66. Nguyen LD, Viscogliosi E, Delhaes L. The lung mycobiome: an emerging field of the human respiratory microbiome. Frontiers Microbiol 2015; 6:89.
67. Marsland BJ, Yadava K, Nicod LP. The airway microbiome and disease. Chest 2013; 144:632-7.
68. Palmer C, Bik EM, DiGiulio DB, Relman DA, Brown PO. Development of the human infant intestinal microbiota. PLoS Biol 2007; 5:e177.
69. Yatsunenko T, Rey FE, Manary MJ et al. Human gut microbiome viewed across age and geography. Nature 2012; 486:222-7.
70. Teo SM, Mok D, Pham K et al. The infant nasopharyngeal microbiome impacts severity of lower respiratory infection and risk of asthma development. Cell Host Microbe 2015; 17:704-15.
71. Marsland BJ, Salami O. Microbiome influences on allergy in mice and humans. Curr Opinion Immunol 2015; 36:94-100.
72. Samuelson DR, Welsh DA, Shellito JE. Regulation of lung immunity and host defense by the intestinal microbiota. Frontiers Microbiol 2015; 6:1085.
73. Schuijt TJ, Lankelma JM, Scicluna BP et al. The gut microbiota plays a protective role in the host defence against pneumococcal pneumonia. Gut 2015; doi:10.1136/gutjnl-2015-309728.
74. Chen YS, Jan RL, Lin YL, Chen HH, Wang JY. Randomized placebo-controlled trial of lactobacillus on asthmatic children with allergic rhinitis. Ped Pulmonol 2010; 45:1111-20.
75. Kalliomaki M, Salminen S, Arvilommi H, Kero P, Koskinen P, Isolauri E Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet 2001; 357:1076-9.
76. Karimi K, Inman MD, Bienenstock J, Forsythe P. Lactobacillus reuteri-induced regulatory T cells protect against an allergic airway response in mice. Am J Respir Crit Care Med 2009; 179:186-93.
77. Zuccotti G, Meneghin F, Aceti A et al. Probiotics for prevention of atopic diseases in infants: systematic review and meta-analysis. Allergy 2015; 70:1356-71.
78. Liu Y, Wang XY, Yang X, Jing S, Zhu L, Gao SH Lung and intestine: a specific link in an ulcerative colitis rat model. Gastroenterol Res Practice 2013; 2013:124530.
79. Bonniere P, Wallaert B, Cortot A et al. Latent pulmonary involvement in Crohn's disease: biological, functional, bronchoalveolar lavage and scintigraphic studies. Gut 1986; 27:919-25.
80. Fireman Z, Osipov A, Kivity S et al. The use of induced sputum in the assessment of pulmonary involvement in Crohn's disease. Am J Gastroenterol 2000; 95:730-4.
81. Waddell A, Ahrens R, Steinbrecher K et al. Colonic eosinophilic inflammation in experimental colitis is mediated by Ly6C(high) CCR2(+) inflammatory monocyte/macrophage-derived CCL11. J Immunol 2011; 186:5993-6003.
82. Asokananthan N, Graham PT, Stewart DJ et al. House dust mite allergens induce proinflammatory cytokines from respiratory epithelial cells: the cysteine protease allergen, Der p 1, activates protease-activated receptor (PAR)-2 and inactivates PAR-1. J Immunol 2002; 169:4572-8.
83. Wan H, Winton HL, Soeller C et al. Der p 1 facilitates transepithelial allergen delivery by disruption of tight junctions. J Clin Invest 1999; 104:123-33.
84. Sporik R, Chapman MD, Platts-Mills TA. House dust mite exposure as a cause of asthma. Clin Exp Allergy 1992; 22:897-906.
85. Tulic MK, Vivinus-Nebot M, Rekima A et al. Presence of commensal house dust mite allergen in human gastrointestinal tract: a potential contributor to intestinal barrier dysfunction. Gut 2015; Gut doi: 10.1136/gutjnl-2015-310523. [Epub ahead of print].
86. Campbell DJ, Butcher EC. Rapid acquisition of tissue-specific homing phenotypes by CD4(+) T cells activated in cutaneous or mucosal lymphoid tissues. J Exp Med 2002; 195:135-41.
87. Eksteen B, Grant AJ, Miles A et al. Hepatic endothelial CCL25 mediates the recruitment of CCR9 + gut-homing lymphocytes to the liver in primary sclerosing cholangitis. J Exp Med 2004; 200:1511-7.
88. Kunkel EJ, Kim CH, Lazarus NH et al. CCR10 expression is a common feature of circulating and mucosal epithelial tissue IgA Ab-secreting cells. J Clin Invest 2003; 111:1001-10.
89. Navarro S, Cossalter G, Chiavaroli C et al. The oral administration of bacterial extracts prevents asthma via the recruitment of regulatory T cells to the airways. Mucosal Immunol 2011; 4:53-65.
90. Atarashi K, Tanoue T, Oshima K et al. Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota. Nature 2013; 500:232-6.
91. Atarashi K, Tanoue T, Shima T et al. Induction of colonic regulatory T cells by indigenous Clostridium species. Science 2011; 331:337-41.
92. Barnes MJ, Powrie F. Immunology. The gut's Clostridium cocktail. Science 2011; 331:289-90.
93. Chinen T, Rudensky AY. The effects of commensal microbiota on immune cell subsets and inflammatory responses. Immunol Reviews 2012; 245:45-55.
94. Ichinohe T, Pang IK, Iwasaki A. Influenza virus activates inflammasomes via its intracellular M2 ion channel. Nature Immunol 2010; 11:404-10.
95. Ichinohe T, Pang IK, Kumamoto Y et al. Microbiota regulates immune defense against respiratory tract influenza A virus infection. PNAS 2011; 108:5354-9.
96. Liu YJ. Thymic stromal lymphopoietin: master switch for allergic inflammation. J Exp Med 2006; 203:269-73.
97. Jariwala SP, Abrams E, Benson A, Fodeman J, Zheng T. The role of thymic stromal lymphopoietin in the immunopathogenesis of atopic dermatitis. Clin Exp Allergy 2011; 41:1515-20.
98. Zhang Z, Hener P, Frossard N et al. Thymic stromal lymphopoietin overproduced by keratinocytes in mouse skin aggravates experimental asthma. PNAS 2009; 106:1536-41.
99. Rimoldi M, Chieppa M, Salucci V et al. Intestinal immune homeostasis is regulated by the crosstalk between epithelial cells and dendritic cells. Nature Immunol 2005; 6:507-14.
100. Takai T. TSLP expression: cellular sources, triggers, and regulatory mechanisms. Allergol International 2012; 61:3-17.
101. Scaldaferri F, Vetrano S, Sans M et al. VEGF-A links angiogenesis and inflammation in inflammatory bowel disease pathogenesis. Gastroenterology 2009; 136:585-95e585.
102. Vargas-Rojas MI, Ramirez-Venegas A, Limon-Camacho L, Ochoa L, Hernandez-Zenteno R, Sansores RH Increase of Th17 cells in peripheral blood of patients with chronic obstructive pulmonary disease. Resp Med 2011; 105:1648-54.
103. Plevy SE, Landers CJ, Prehn J et al. A role for TNF-alpha and mucosal T helper-1 cytokines in the pathogenesis of Crohn's disease. J Immunol 1997; 159:6276-82.
104. Reed CE, Kita H. The role of protease activation of inflammation in allergic respiratory diseases. J Allergy Clin Immunol 2004; 114:997-1008; quiz 1009.
105. Hansbro PM, Hamilton MJ, Fricker M et al. Importance of mast cell Prss31/transmembrane tryptase/tryptase-gamma in lung function and experimental chronic obstructive pulmonary disease and colitis. J Biol Chem 2014; 289:18214-27.
106. Keely S, Hansbro PM. Lung-gut cross talk: a potential mechanism for intestinal dysfunction in patients with COPD. Chest 2014; 145:199-200.